We help our members discover, develop, and deliver innovative medicines and vaccines.
Our membership consists of more than 50 companies, from established organizations to fledgling startups, all of whom are revolutionizing healthcare through the discovery and development of new medicines and vaccines.
Guided by a strict Code of Ethical Practices, we work with governments, insurance companies, healthcare professionals and stakeholders to advance the field and enhance the wellbeing of Canadians. We are committed to being valued partners in Canada’s healthcare system.
We aim to achieve these goals by forming effective alliances, supporting policies, improving Canada’s regulatory environment, widening access to innovative medicines and ensuring the effective protection of intellectual property.
Novo Nordisk Canada Inc. is an affiliate of Novo Nordisk A/S, a global healthcare company with more than 90 years of innovation and leadership in diabetes care.
This heritage has given them experience and capabilities that enable them to help people defeat other serious chronic conditions such as hemophilia, growth disorders and obesity.
Innovacorp is Nova Scotia’s early stage venture capital organization. We find, fund and foster innovative Nova Scotia start-ups that strive to change the world.
We’re especially interested in start-ups in the information technology, life sciences, clean technology and ocean technology sectors. We want to help those companies commercialize their technologies and succeed in the global marketplace.
Accessible, independent, knowledgeable and experienced, we are committed to being proactive in bringing our clients timely information and advice, and our partners are accessible to our clients. We provide a team-based approach and dedication to partner or senior professional involvement and regular client contact—for every client, for every engagement.
AstraZeneca is a science-led biopharmaceutical company pushing the boundaries of science to deliver life-changing medicines.
The company employs more than 700 people in Canada who work to research, develop and market innovative medicines. AstraZeneca Canada was recently designated a global Clinical Hub for oncology and immuno-oncology clinical studies. We are currently leading global oncology clinical studies in lung, head and neck cancer.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalized healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Springboard Atlantic provides resources to Atlantic Canadian universities and colleges to help them transfer knowledge and technology to our region’s private sector. Our network members are from thirteen of the universities in Atlantic Canada and the five community colleges.
Springboard’s network members work to connect publicly-funded research with industry experts through a range of programs and services. Springboard also connects skilled professionals in academia and industry to create new collaborations.
IMV Inc. (formerly known as Immunovaccine Inc.) develops cancer immunotherapies and infectious disease vaccines based on the Company’s DepoVax™ platform.
Encouraging the country’s international trade and leading Canada’s international development and humanitarian assistance.